Clinical Trial Update: T2007-002 Clofarabine, Etoposide, Cyclophosphamide in Relapsed Acute Myelogenous Leukemia (AML) [Phase 2]

View source ↗

Summary

Phase 2 trial of Clofarabine, Etoposide, and Cyclophosphamide in relapsed acute myeloid leukemia was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Clofarabine, etoposide, cyclophosphamide

Snippet

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium | Conditions: Relapsed Acute Myelogenous Leukemia | Phase 2 | Status: TERMINATED | Results posted: 2020-02-19